MedPath

Assisted Reproductive Technology in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (ARTiMS) study. A prospective, longitudinal study.

Not Applicable
Recruiting
Conditions
Pregnancy
Multiple Sclerosis
sub-fertility
Neuromyelitis Optica Spectrum Disorders
Neurological - Multiple sclerosis
Neurological - Other neurological disorders
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Registration Number
ACTRN12623001310651
Lead Sponsor
John Hunter Hospital of the Hunter New England Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
25
Inclusion Criteria

Inclusion criteria are women who:
1) Have been diagnosed with MS or NMOSD
2) Who are planning to use ART to fall pregnant within 3 years of study start
3) Who attend one of the 8 MS specialist centres who use MSBase.
4) Who are >18 years of age and <55 years of age

Exclusion Criteria

1) Women who fall pregnant by means other than ART.
2) Male genetic sex

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath